GeneOneLifeScience Inc. | |
Stock Exchange | Korea Exchange Commodity Market |
EPS |
KRW444.89 |
Market Cap |
KRW93.42 B |
Shares Outstanding |
21.19 M |
Public Float |
18.38 M |
Address |
Unit 1903, Keungil Tower Seoul SL 06142 Korea, Republic Of |
Employees | - |
Website | http://www.genels.com |
Updated | 07/08/2019 |
GeneOne Life Science, Inc. engages in the research, development, and manufacture of deoxyribonucleic acid (DNA) vaccines for the prevention and treatment of diseases. Its products include VGX-3400, VGX-3500, and fluprime. Its service include process cost analysis, sterility testing, research batch production, strain selection, cell bank characterization, and others. |